Make Way for CalIBR

Merck this week launched the California Institute for Biomedical Research, or CalIBR, "a new nonprofit research institute to help academics turn their basic biology insights into drug compounds ready for human tests," Science reports, adding that the pharmaceutical company is contributing $42 million over the first three years, and possibly as much as $90 million over the first seven years, to the institute.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.